blank Quick help
blank Maintenance news

Dates prévues pour la maintenance

Interruptions régulières:
entre 5 h 00 et 5 h 15 HEC, du lundi au dimanche.

Autres interruptions
Accessibilité

2022.02.11

More...
blank News flashes

Flash Info

La Lettonie participe au Registre fédéré
Cliquez ici pour plus d'informations sur le Registre fédéré.

2025-04-16

More...
blank Related links

Notifications
Assistant du Registre européen des brevets
Manuel d’utilisation du Registre européen des brevets
Registre européen des brevets – guide de poche
FAQ - Registre européen des brevets
Registre fédéré (Flyer)
Dossier mondial (Flyer)
Événements du Registre
Couverture de données pour lien profonds
Contenue du Registre fédéré
Tour de l'information brevets
Charte d'utilisation équitable

Extract from the Register of European Patents

EP About this file: EP3006455

EP3006455 - FRAGMENT FC D'IGG4 COMPRENANT UNE RÉGION CHARNIÈRE MODIFIÉE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.05.2019
Database last updated on 30.04.2025
FormerThe patent has been granted
Status updated on  01.06.2018
FormerGrant of patent is intended
Status updated on  13.12.2017
FormerExamination is in progress
Status updated on  16.06.2017
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
Hanmi Pharm. Co., Ltd.
214 Muha-ro
Paltan-myeon
Hwaseong-si, Gyeonggi-do 445-958 / KR
[2016/15]
Inventor(s)01 / JUNG, Sung Youb
550, Dongtangiheung-ro
Hwaseong-si
Gyeonggi-do 18469 / KR
02 / HUH, Yong Ho
109-204
102 Sadang-ro 2ga-gil
Dongjak-gu
Seoul 156-744 / KR
03 / PARK, Sung Hee
603-1804
209 Pangyowon-ro
Bundang-gu
Seongnam-si Gyeonggi-do 463-959 / KR
04 / LEE, Jong Soo
310-1601
72 Jeongjail-ro
Bundang-gu
Seongnam-si Gyeonggi-do 463-725 / KR
05 / CHOI, In Young
105-1801
70 Yonggu-daero2771beon-gil
Suji-gu
Yongin-si Gyeonggi-do 448-755 / KR
 [2016/23]
Former [2016/15]01 / JUNG, Sung Youb
109-105
373 Gwongwang-ro
Paldal-gu
Suwon-si Gyeonggi-do 442-754 / KR
02 / HUH, Yong Ho
109-204
102 Sadang-ro 2ga-gil
Dongjak-gu
Seoul 156-744 / KR
03 / PARK, Sung Hee
603-1804
209 Pangyowon-ro
Bundang-gu
Seongnam-si Gyeonggi-do 463-959 / KR
04 / LEE, Jong Soo
310-1601
72 Jeongjail-ro
Bundang-gu
Seongnam-si Gyeonggi-do 463-725 / KR
05 / CHOI, In Young
105-1801
70 Yonggu-daero2771beon-gil
Suji-gu
Yongin-si Gyeonggi-do 448-755 / KR
Representative(s)Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
[N/P]
Former [2016/15]Andrews, Robert, et al
Mewburn Ellis LLP
City Tower
40 Basinghall Street
London EC2V 5DE / GB
Application number, filing date14804503.229.05.2014
[2016/15]
WO2014KR04799
Priority number, dateKR2013006302931.05.2013         Original published format: KR 20130063029
[2016/15]
Filing languageKO
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014193173
Date:04.12.2014
Language:KO
[2014/49]
Type: A1 Application with search report 
No.:EP3006455
Date:13.04.2016
Language:EN
[2016/15]
Type: B1 Patent specification 
No.:EP3006455
Date:04.07.2018
Language:EN
[2018/27]
Search report(s)International search report - published on:KR04.12.2014
(Supplementary) European search report - dispatched on:EP29.09.2016
ClassificationIPC:C07K7/08, C12N15/13, C12N15/63, A61K47/42
[2016/15]
CPC:
A61K38/193 (EP,US); C07K7/08 (KR); A61K47/42 (KR);
A61K47/60 (EP,US); A61K47/68 (EP,US); A61K47/6813 (EP,US);
A61K47/6849 (EP,US); A61P43/00 (EP); C07K14/47 (EP,US);
C07K16/2803 (US); C12N15/11 (KR); C12N15/63 (KR);
C07K2317/40 (US); C07K2317/52 (EP,US); C07K2317/53 (EP,US);
C07K2317/94 (US); C07K2319/30 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/15]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:IGG4-FC-FRAGMENT MIT MODIFIZIERTEM SCHARNIERBEREICH[2016/15]
English:IGG4 FC FRAGMENT COMPRISING MODIFIED HINGE REGION[2016/15]
French:FRAGMENT FC D'IGG4 COMPRENANT UNE RÉGION CHARNIÈRE MODIFIÉE[2016/15]
Entry into regional phase08.12.2015Translation filed 
18.12.2015National basic fee paid 
18.12.2015Search fee paid 
18.12.2015Designation fee(s) paid 
18.12.2015Examination fee paid 
Examination procedure18.12.2015Examination requested  [2016/15]
26.04.2017Amendment by applicant (claims and/or description)
20.06.2017Despatch of a communication from the examining division (Time limit: M04)
24.10.2017Reply to a communication from the examining division
14.12.2017Communication of intention to grant the patent
20.04.2018Fee for grant paid
20.04.2018Fee for publishing/printing paid
20.04.2018Receipt of the translation of the claim(s)
Divisional application(s)EP18168489.5  / EP3406627
Opposition(s)05.04.2019No opposition filed within time limit [2019/24]
Fees paidRenewal fee
24.05.2016Renewal fee patent year 03
25.05.2017Renewal fee patent year 04
25.05.2018Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL04.07.2018
CY04.07.2018
EE04.07.2018
LV04.07.2018
MC04.07.2018
MK04.07.2018
MT04.07.2018
RS04.07.2018
SI04.07.2018
SM04.07.2018
IS04.11.2018
[2022/31]
Former [2021/34]AL04.07.2018
CY04.07.2018
EE04.07.2018
LV04.07.2018
MC04.07.2018
MT04.07.2018
RS04.07.2018
SI04.07.2018
SM04.07.2018
IS04.11.2018
Former [2021/26]AL04.07.2018
CY04.07.2018
EE04.07.2018
LV04.07.2018
MC04.07.2018
RS04.07.2018
SI04.07.2018
SM04.07.2018
IS04.11.2018
Former [2020/07]AL04.07.2018
EE04.07.2018
LV04.07.2018
MC04.07.2018
RS04.07.2018
SI04.07.2018
SM04.07.2018
IS04.11.2018
Former [2019/37]AL04.07.2018
EE04.07.2018
LV04.07.2018
RS04.07.2018
SI04.07.2018
SM04.07.2018
IS04.11.2018
Former [2019/26]AL04.07.2018
EE04.07.2018
LV04.07.2018
RS04.07.2018
SM04.07.2018
IS04.11.2018
Former [2019/24]AL04.07.2018
EE04.07.2018
LV04.07.2018
RS04.07.2018
IS04.11.2018
Former [2019/13]AL04.07.2018
LV04.07.2018
RS04.07.2018
IS04.11.2018
Former [2019/11]RS04.07.2018
IS04.11.2018
Former [2019/08]IS04.11.2018
Documents cited:Search[A]WO2008082274  (HANMI PHARMACEUTICAL CO LTD [KR], et al) [A] 1-21* the whole document *
International search[X]WO2005047334  (HANMI PHARM IND CO LTD [KR], et al);
 [A]US7968316  (JUNG SUNG YOUB [KR], et al);
 [A]US2012100140  (REYES CHRISTOPHER L [US], et al);
 [A]WO2012083370  (CEPHALON AUSTRALIA PTY LTD [AU], et al);
 [A]US2012276097  (YANG SEHWAN [KR], et al)
by applicantUS5349053
 WO9632478
 US5585097
 WO9734631
    - COLE ET AL., J. IMMUNOL., (1997), vol. 159, pages 3613 - 3621
    - VAN DER NEUT KOLFSCHOTEN ET AL., SCIENCE, (2007), vol. 317, pages 1554 - 1557
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.